A Study of REGN7544 for the Treatment in Adult Patients With Sepsis-Induced Hypotension

PHASE2RecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

May 5, 2025

Primary Completion Date

July 23, 2026

Study Completion Date

October 19, 2026

Conditions
Sepsis-Induced Hypotension
Interventions
DRUG

REGN7544

Administered per the protocol

DRUG

PB

Administered per the protocol

Trial Locations (25)

10461

RECRUITING

Montefiore Medical Center - Weiler Hospital, The Bronx

10467

RECRUITING

Montefiore Medical Center - Moses Campus, The Bronx

21287

RECRUITING

Johns Hopkins Hospital, Baltimore

27157

RECRUITING

Atrium Health, Winston-Salem

29425

RECRUITING

MUSC SCTR Research Nexus Clinic and Lab, Charleston

30322

RECRUITING

Emory University Hospital, Atlanta

37000

RECRUITING

Centre Hospitalier Regional Universaitaire de Tours (CHRU de Tours), Tours

37232

RECRUITING

Vanderbilt University Medical Center, Nashville

44093

RECRUITING

CHU Nantes, Nantes

44195

RECRUITING

Cleveland Clinic Foundation, Cleveland

45064

RECRUITING

Centre Hospitalier Universitaire d'Orleans, Orléans

49933

RECRUITING

Centre Hospitalier Universitaire Angers, Angers

51100

RECRUITING

CHU de Reims Hopital Robert Debre, Reims

67091

RECRUITING

Hopitaux Universitaires de Strasbourg, Strasbourg

72037

RECRUITING

Centre Hospitalier Le Mans, Le Mans

75014

RECRUITING

Hopital Cochin, Paris

84107

RECRUITING

Intermountain Medical Center - Murray (Pulmonary Medicine), Murray

85925

RECRUITING

Centre Hospitalier Departemental (CHD) Vendee, La Roche-sur-Yon

87042

RECRUITING

CHU Dupuytren, Limoges

90400

RECRUITING

Hopital Nord Franche Comte, Trévenans

92380

RECRUITING

Raymond Poincare University Hospital, Garches

94270

RECRUITING

Paris-Saclay University Hospitals, Le Kremlin-Bicêtre

06510

RECRUITING

Yale University, New Haven

02114

RECRUITING

Massachusetts General Hospital, Boston

02215

RECRUITING

Harvard Medical School - Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY

NCT06608901 - A Study of REGN7544 for the Treatment in Adult Patients With Sepsis-Induced Hypotension | Biotech Hunter | Biotech Hunter